SCHEMBL5023388

SCHEMBL5023388

Cc1cc2c(cc1C(C)C)N(C)CCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
GAA P10253 4/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 3/20 0.36
GLA P06280 2/20 0.36
CASP1 P29466 2/20 0.36
LMNA P02545 2/20 0.35
USP2 O75604 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HSP90AA1 P07900 2/20 0.33
WDR5 P61964 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15628980 0.82 ALDH1A1 (0.50) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL15625437 0.82 ALDH1A1 (0.34) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL12428932 0.76 HSD17B10 (0.46) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL14492579 0.75 ALDH1A1 (0.34) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL26700013 0.73 TNKS (0.38) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL24405342 0.72 HSD17B10 (0.50) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL8738948 0.71 ALDH1A1 (0.55) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL13252969 0.71 ALDH1A1 (0.44) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL25897067 0.71 AR (0.39) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL16687894 0.70 AR (0.41) ALDH1A1GAAHPGDMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012064744-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORϒ ACTIVITY AND THE TREATMENT OF DISEASE LYCERA CORPORATION (US) 2012-05-18 WO disclosed